In-vitro dissolution testing of 5-aminosalicylic acid release from pH dependent mesalazine formulations

被引：0
|
作者：
Kruis, Wolfgang [2 ]
Greinwald, Roland [1 ]
Fingerhut, Thomas [3 ]
机构：
[1] Dr Falk Pharma GmbH, Res & Dev, Freiburg, Germany
[2] Univ Cologne, Evangel Krankenhaus Kalk, Cologne, Germany
[3] Dr Falk Pharma GmbH, Qual Assurance & Qual Control, Freiburg, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2011年 / 5卷 / 05期
关键词：
ACTIVE ULCERATIVE-COLITIS; DOUBLE-BLIND; PELLETS; TABLETS; TRIAL;
D O I：
10.1016/j.crohns.2011.04.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：499 / 500
页数：2
相关论文
共 50 条
  • [41] Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine
    Karamanolis, DG
    Papatheodoridis, GV
    Xourgias, V
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (11) : 1083 - 1088
  • [42] Controlled Release of 5-Aminosalicylic Acid (5-ASA) from New Biodegradable Polyurethanes
    Kenawy, El-Refaie
    Al-Deyab, Salem S.
    El-Newehy, Mohamed H.
    MOLECULES, 2010, 15 (04) : 2257 - 2268
  • [43] RETROGRADE SPREAD OF MESALAZINE (5-AMINOSALICYLIC ACID)-CONTAINING ENEMA IN PATIENTS WITH ULCERATIVE-COLITIS
    TIELVANBUUL, MMC
    MULDER, CJJ
    VANROYEN, EA
    WILTINK, EHH
    TYTGAT, GNJ
    CLINICAL PHARMACOKINETICS, 1991, 20 (03) : 247 - 251
  • [44] Controlled release of 5-aminosalicylic acid from a new pH responsive polymer derived from tamarind seed polysaccharide, acrylic acid, and polyamidoamine
    Dey, R. K.
    Tiwary, G. S.
    Patnaik, Tanushree
    Jha, Usha
    POLYMER BULLETIN, 2011, 66 (05) : 583 - 598
  • [45] Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine
    Tzivras, M
    Konstandinidis, A
    Hatzis, G
    Paraskeva, K
    Skandalis, N
    Archimandritis, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (07) : 729 - 730
  • [46] ORAL MESALAZINE (5-AMINOSALICYLIC ACID - ASACOL) FOR THE PREVENTION OF POSTOPERATIVE RECURRENCE OF CROHNS-DISEASE
    CAPRILLI, R
    ANDREOLI, A
    CAPURSO, L
    CORRAO, G
    DALBASIO, G
    GIOIENI, A
    LANFRANCHI, GA
    PALADINI, I
    PALLONE, F
    PONTI, V
    RIGO, GP
    ROSSINI, FP
    STURNIOLO, GC
    TONELLI, F
    VALPIANI, D
    LATELLA, G
    FRIERI, G
    VERNIA, P
    VISCIDO, A
    VALENTI, M
    TORCHIO, P
    TRAGNONE, A
    SALVADORI, G
    FERRETTI, P
    VANNOZZI, G
    MIGLIO, F
    MASTRONARDI, M
    CODELUPPI, PL
    MONTINO, MC
    DINCA, R
    DAGOSTINO, L
    LORENZETTI, R
    CIACO, A
    PAPI, A
    LUMINARI, M
    BERTONE, A
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1994, 8 (01) : 35 - 43
  • [47] Controlled release of 5-aminosalicylic acid from a new pH responsive polymer derived from tamarind seed polysaccharide, acrylic acid, and polyamidoamine
    R. K. Dey
    G. S. Tiwary
    Tanushree Patnaik
    Usha Jha
    Polymer Bulletin, 2011, 66 : 583 - 598
  • [48] INFLUENCE OF HYDROPHILIC ADDITIVES ON 5-AMINOSALICYLIC ACID RELEASE RATE FROM MATRIX PELLETS
    DEBRANT, V
    REMON, JP
    5TH INTERNATIONAL CONFERENCE ON PHARMACEUTICAL TECHNOLOGY, VOLS 1-5, 1989, : 222 - 230
  • [49] Obtaining the palygorskite:chitosan composite for modified release of 5-aminosalicylic acid
    Gramoza Vilarinho Santana, Ana Cristina Sousa
    Soares Sobrinho, Jose Lamartine
    da Silva Filho, Edson Cavalcanti
    Cunha Nunes, Livio Cesar
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 73 : 245 - 251
  • [50] Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers
    Brunner, M
    Greinwald, R
    Kletter, K
    Kvaternik, H
    Corrado, ME
    Eichler, HG
    Müller, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (09) : 1163 - 1169
12345